Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Josef S Smolen, Robert Landewé, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases · 2022 · 1.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism · 2005 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +17

Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based study

Michele F. Doran, Cynthia S. Crowson, Gregory R. Pond et al. · Arthritis & Rheumatism · 2002 · 1.2K citations

Medicine, Infectious Diseases, Internal Medicine +16

Cardiovascular death in rheumatoid arthritis: A population‐based study

Hilal Maradit Kremers, Paulo Nicola, Cynthia S. Crowson et al. · Arthritis & Rheumatism · 2005 · 939 citations

Medicine, Clinical Sciences, Internal Medicine +16

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Arteriosclerosis Thrombosis and Vascular Biology · 2021 · 700 citations · Full text

Medicine, Cardiology, Genetics +14